Search results
Q3 2023 CureVac NV Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Alexander Zehnder; CEO, MD & Member of Management Board; CureVac N.V. Marcus Dalton Myriam Mendila; Chief Development Officer, MD & Member of the Management Board; CureVac N.V.
UPDATE 1-CureVac files expanded patent lawsuit against Pfizer/BioNTech over mRNA technology
Reuters via Yahoo Finance· 1 year agoCureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech over the use of mRNA technology and that a U.S. court had granted its request to ...
US court grants CureVac's request to transfer Pfizer/BioNTech's COVID vaccine patent case
Reuters via Yahoo Finance· 1 year agoMay 19 (Reuters) - CureVac NV said on Friday its request to transfer the ongoing patent litigation filed by Pfizer Inc and its German partner BioNTech to the Eastern District of Virginia from ...
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For...
Benzinga via Yahoo Finance· 2 years agoResearchers are working on an experimental pan-influenza vaccine based on the famed mRNA technology...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 3 weeks ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
Benzinga via Yahoo Finance· 1 year agoA High Court battle between Pfizer Inc (NYSE: PFE), its partner BioNTech SE (NASDAQ: BNTX) locked in...
Wilders Taps Former Labor Minister as Dutch Coalition Negotiator
Bloomberg via Yahoo News· 6 months ago(Bloomberg) -- Far-right lawmaker Geert Wilders’ attempts to form a cabinet began anew with the...